High-Sensitivity Troponin (hs-Troponin)

Introduction

High-sensitivity troponin (hs-Troponin) is a biomarker used to detect heart muscle damage. It plays a crucial role in diagnosing acute coronary syndrome (ACS) and myocardial infarction (heart attack).

What is hs-Troponin?

hs-Troponin is a more sensitive version of traditional troponin tests. It can detect even very low levels of cardiac troponin in the blood, allowing early identification of heart damage.

Why is hs-Troponin Important?

  • Early Diagnosis of Heart Attacks: It helps doctors detect heart attacks earlier.
  • Risk Stratification: It allows the assessment of patients at risk for future heart problems.
  • Differentiation of Cardiac vs. Non-Cardiac Causes: It helps distinguish whether chest pain is due to heart problems or other conditions.

Interpretation of hs-Troponin Levels

  • Normal values: Very low or undetectable levels suggest no heart damage.
  • Elevated values: High levels may indicate acute myocardial infarction, myocarditis, or other cardiac diseases.
  • Serial Testing: hs-Troponin is often measured multiple times to detect trends – a rapid increase suggests an ongoing heart attack.

Clinical Use

  • Emergency Room Evaluation: Used for patients presenting with chest pain.
  • Cardiac Risk Assessment: Helps in predicting cardiovascular events in seemingly healthy individuals.
  • Monitoring of Cardiac Conditions: Used for follow-up in patients with known heart disease.

Important Considerations

  • High levels may also be seen in conditions like kidney disease, sepsis, and heart failure.
  • Not all elevated readings mean a heart attack; clinical correlation is essential.

Conclusion

hs-Troponin is a valuable tool for early detection and risk assessment of heart disease. Understanding its role helps doctors provide timely and accurate care.

Source recommendations

1. European Society of Cardiology Guidelines on the Fourth Universal Definition of Myocardial Infarction

  1. https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Fourth-Universal-Definition-of-Myocardial-Infarction
  2. https://academic.oup.com/eurheartj/article/40/3/237/5079081
  3. https://pubmed.ncbi.nlm.nih.gov/30571511/
  4. https://www.acc.org/Latest-in-Cardiology/ten-points-to-remember/2018/08/24/00/09/Fourth-Universal-Definition-of-MI-ESC-2018
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC8078947/

2. American Heart Association Guidelines on Acute Coronary Syndrome

  1. https://www.heart.org/en/health-topics/heart-attack/about-heart-attacks/acute-coronary-syndrome
  2. https://professional.heart.org/en/guidelines-statements
  3. https://www.ahajournals.org/doi/10.1161/cir.0000000000000134
  4. https://professional.heart.org/en/education/ntse-acs-for-professionals
  5. https://pubmed.ncbi.nlm.nih.gov/25260718/

Our advantages:

patient2376100
Best practices from USA, EU and Japan
Our answers to your questions are based on the clinical recommendations of countries with the most developed healthcare systems in the field of cardiology in the USA, the EU and Japan.
prescription18648039
Always up-to-date information
On a daily basis, we monitor for you all new scientific research publications in leading scientific journals on medical issues of interest to you.
We monitor all innovations and changes in the field of cardiac disease treatment on a daily basis.
fvfflf7q
Get second opinion
Here you can learn everything that even your doctor may not know about cardiology (if he does not speak English and he does not read 117 leading medical journals on cardiology every month).
1xr4duup
The most comprehensive and up-to-date collection of free cardiology materials
Our website contains the most comprehensive and up-to-date collection of free cardiology materials in your country.
Every 3-5 years, half of the scientific approaches to treatment in the field of cardiology are reviewed as a result of specialized scientific discoveries. With us, you don't have to wait these years to learn about the best ways to treat you and your loved ones.
arrow
Please register in order to receive information regarding possible complications and new approaches to treatment of cardiovascular diseases via email in our Newsletters.
arrow